The Pharmaceutical Market: Philippines

Publication Date	February 2008
Publisher	Espicom
Product Type	Report
Pages	80
ISBN Number	not applicable
Product Code	ESP00281

Price

£595.00
approximately: $1,194 | €747

PDF

PRINT £595 ($1,194 | €747)

Order above formats by FAX

Summary

The Philippines is a relatively poor country where only a small majority of the population has access to adequate healthcare provision and even fewer can afford the high drug prices. The government has been actively promoting the use of generics in recent years, as branded pharmaceuticals are expensive in a country with very low GDP per capita. There is a large potential market for generics, but sales have been low. The government has been criticised in the past for not doing enough to promote generics and has recently stepped up its efforts, launching Project 100 in 2008 for example, which promises to offer cheap generics at 100 public hospitals around the country.

Changes to be brought by the controversial Cheaper Medicine Bill will impact the Philippines pharmaceutical market in a number of areas, including IP laws, competition and drug price control mechanisms. The market is expected to be especially volatile in the 2008-2010 period.

Domestic manufacturing is limited and imports make up a large proportion of the market. The parallel importation of drugs and the wrangling of intellectual property right issues between the multinational pharmaceutical industry and the government have been contentious issues in recent times. Administration of the health sector is highly devolved to local government units. This can make planning and co-ordination difficult. Between 50% and 60% of healthcare expenditure and provision is in the private sector.

Much of the market is based in and around Manila in southern Luzon. It is here where disposable incomes are highest, and where the majority of the country's high class medical facilities and staff are located. An exodus of medical staff overseas in pursuit of better wages and working conditions has put severe pressure on healthcare services. The Philippines has around 1.2 doctors per thousand population.

Content

Background Data
- Geography
- Political Overview
- Economic Overview
  - Economic projections 2008-2013
- Population
  - Population by Region, 1995-2006
- Population Growth
  - Population projections for 2008-2013
- Demographic Indicators
  - Principal Demographic Indicators, 2000-2006
  - Live Births by Gender and Weight 2004
  - Live births by Location, 2006
  - Deliveries by Attendant, 2006
- Mortality
  - Causes of Death, 2000-2002
- Infant Mortality
  - Leading Reported Causes of Infant Mortality, 2000-2002
- Morbidity
  - Reported Notifiable Diseases/Conditions, 2004
    - HIV/AIDS
    - Living Conditions Affecting Healthcare
  - Households with Access to Clean Water and Sanitary Toilets, 2006
- Charts
  - Map of the Philippines
  - Population by Age Group, 2005 (%)
Healthcare System
- Organisation & Administration
- Health Expenditure
  - Total Health Expenditure, 1994-2004
  - Health Expenditure by Source of Funding, 2004
  - Health Expenditure by Source of Funding, 1994-2004 (% of Total)
- Hospital Services
  - Hospitals by Sector, 1990-2005
  - Hospitals by Region, 2005
  - Hospital Beds, 1987-2005
    - Classification of Hospitals and Other Healthcare Facilities
  - Distribution of Public Hospitals by Type & Bed, 2005
  - Distribution of Private Hospitals by Type & Bed, 2005
  - Distribution of Other Public Health Facilities, 2005
  - Distribution of Other Private Health Facilities, 2005
  - Total Public Facilities and Beds, 2005
  - Total Private Facilities and Beds, 2005
- Ambulatory Care
  - Public Outpatient Facilities, 1987-2006
  - Barangay Health Stations by Region, 2006
  - Distribution of Barangay Health Workers by Region, 2004
- Medical Personnel
  - Medical Personnel, 2005
  - Other Government Medical Personnel by Region, 2004
- Charts
  - Health Expenditure by Source of Funding, 1994-2004 (%)
  - Hospital Beds, Total & per 000 Population, 1976-2005
Accessing The Pharmaceutical Market
- Introduction
- Regulatory Environment
  - National Drug Policy
- Pharmaceutical Registration/Drug Approval Process
  - Labelling
  - Clinical trials
  - Fast Track Registrations
- Patent Protection & Intellectual Property Rights
  - Counterfeit Drugs
- Distribution Channels
  - Registered Pharmaceutical Suppliers, 1994-2003
  - Drug Wholesalers/Retailers by Region, 2003
- Distributors
- Domestic Production
  - Registered Drug Manufacturers, 1994-2003
  - Registered Drug Manufacturers and Traders by Region, 2003
- Domestic Producers
- Directory
  - Government Organisations
  - Trade Associations